CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home »

ONCOLOGY. Vol. 14 No. 7
The Gerszten/Welch Article Reviewed 

Current Surgical Management of Metastatic Spinal Disease

By Christopher B. Michelsen, MD, Columbia University, College of Physicians and Surgeons, New York Presbyterian Hospital, New York, New York | July 1, 2000

The article entitled “The Current Surgical Management of Metastatic Spinal Disease,” by Drs. Peter C. Gerszten and William C. Welch, is a timely, comprehensive review of the current state of the art in the diagnosis and surgical management of spinal metastatic disease. The authors begin by describing the clinical problem and noting the high prevalence of spinal column metastases and cord compression associated with breast, bronchogenic, prostatic, and other types of primary malignancies. They also note that this will likely become an even more common clinical challenge as diagnostic and oncologic treatment modalities continue to improve.

The authors proceed to describe an accepted clinical approach to the evaluation and diagnosis of these patients. The clinical presentation is reviewed, and diagnostic imaging modalities are discussed. Although plain films are an excellent screening tool, the authors emphasize the utility of magnetic resonance imaging (MRI) in the evaluation of metastatic disease. The advantages of MRI include increased sensitivity (eg, for noncontiguous lesions, which often are missed) and the ability to evaluate both cord impingement and soft-tissue extension. Thus, MRI has become the imaging modality of choice in the evaluation of spinal metastatic disease. The roles of computed tomography (CT) and nuclear studies are also discussed.

Treatment Options

The authors then review the treatment options for spinal metastatic disease and the role of surgery in treatment. Indications for surgery can include a need for biopsy tissue, radioresistant tumors, spinal instability due to destruction of the bony elements, canal compromise, poor response to radiotherapy, tumor recurrence, and pain relief.

In discussing surgical indications, the authors make an important distinction. Radiotherapy was previously the universally accepted primary treatment for spinal metastatic disease, and this was due, in part, to the somewhat disappointing results of surgical treatment. However, many older series were based on the results of laminectomy to decompress the neural elements.

Laminectomy is a posterior procedure that was performed in the hopes of obtaining an indirect decompression of the neural elements. Because neural element compression with metastatic disease occurs most often ventrally (ie, tumors are most commonly found in the vertebral body), prior surgical treatment often did not produce an adequate decompression.

Modern surgical techniques have allowed direct anterior decompression. Spinal stability can then be effectively restored with bone graft or methylmethacrylate, and appropriate spinal instrumentation (cages, plates, and rods) can be applied both anteriorly and posteriorly. In most cases, surgical decompression and stabilization of the involved spinal segment should precede radiotherapy to avoid possible wound healing complications.

Surgical Interventions

These modern techniques have led to a significant improvement in results compared to the historical results of laminectomy alone. Thus, surgery has become the treatment of choice in selected cases, and early surgical consultation can, at times, prevent unnecessary prolonged pain and neurologic deterioration. The authors emphasize the need for a multidisciplinary approach to these patients, including an in-depth discussion with the patient, his or her family, and other caregivers. The decision to intervene surgically must always be made in light of the patient’s prognosis and expected survival.

Surgical options in the anatomic regions of the spine are then explored. In the cervical spine, anterior corpectomy and reconstruction with autograft, allograft, or methylmethacrylate can be used when the tumor mass is primarily in the vertebral body and compression is occurring anteriorly. However, the anterior approach provides limited ability to approach posterolateral tumor masses. In these cases, a posterior laminectomy approach is best, but as the authors point out, there is the danger of possible posterior cord displacement if the cord is compressed anteriorly.

Thoracic tumors are then discussed, beginning with the problems associated with traditional laminectomy techniques, including progressive kyphosis and continued neurologic deterioration. Anterior approaches—or in selected patients, posterolateral approaches (for example, costotransversectomy)—are generally preferred. Minimally invasive tools such as thoracoscopy are exciting adjunctive options, which hold much promise for the future. Decompression and fusion techniques in the lumbar spine can be performed anteriorly, posteriorly, or with a combination of both approaches.

Finally, prognosis and complications are reviewed. The authors point out the high rate of neurologic recovery, with over 65% of previously paraplegic patients regaining functional ambulation. Neurologic outcome tends to be better in patients with incomplete deficits and those with a more gradual onset of symptoms.

Conclusions

Overall, the authors give an excellent, comprehensive review of the surgical treatment of metastatic spine disease, which is accessible and relevant to surgeon and nonsurgeon alike. The role of surgery continues to evolve but clearly is increasingly important. Timely reviews of the literature such as this one can help to better define that role and ensure that surgical modalities will be applied most appropriately to patients who will benefit most from them.

—Christopher Michelsen, md


 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.



Peter C. Gerszten, MD, MPH and William C. Welch, MD, FACS



 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
IMAGE IQ

Lower Back Pain in an Elderly Man With a History of Localized Prostate Cancer
James B. Yu, MD1 , May 17, 2013

A 70-year-old man with a history of localized prostate cancer treated with whole-pelvis radiation therapy with a boost to the prostate, in conjunction with androgen deprivation therapy 7 years prior, presented with lower back pain. A bone scan revealed an area of activity in the sacrum. What is the most likely diagnosis?

More Image IQs 

 
FROM PHYSICIANS PRACTICE
Primary Care Can't Thrive Without Nurse Practitioners
Courtney H. Lyder, ND,  May 17, 2013
With a projected shortfall of primary-care physicians, it's time for alternate solutions to patient care. Nurse practitioners are one logical remedy.
VWhat Physicians Can Learn from the Allscripts EHR Lawsuit
Marisa Torrieri,  May 16, 2013
Lawsuit prompts question: What should physicians do to ensure they end up with a great EHR instead of buyer’s remorse?
Eight Ways ICD-9 Will Still Matter to Medical Practices
Brenda Edwards, CPC,  May 15, 2013
What should your medical practice do with your ICD-9-CM book after October 1, 2014? Keep it.
Seven Ways Technology Can Speed Up Patient Collections
Cheyenne Brinson,  May 15, 2013
Failing to adopt widely available billing and collections technology can cost medical practices big. Here's how to do it right.
Four Reasons Private Medical Practice is Becoming Extinct
Carol Stryker,  May 15, 2013
It’s becoming increasingly difficult for private medical practices to thrive. Here’s what’s driving the trend toward consolidation.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Colorectal Lesions
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Skin Lesions
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Colorectal Lesions
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • New AUA Guidelines for Prostate Cancer Screening
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • Genomics Studies Identify Testicular Cancer Risk Variants
  • Lower Back Pain in an Elderly Man With a History of Localized Prostate Cancer
  • FDA Approves Erlotinib (Tarceva) as First-Line Lung Cancer Therapy for Certain Patients
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • “This Is My Last Day on Earth”
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Patient Quality of Life Endpoints in Oncology Trials, Part II
  • Who's Coding Whom?
  • “How Do I Say This Nicely? Your Oncologist Wasn't Following Guidelines”
  • Cancer Metabolism as a Therapeutic Target
  • Study: Cholesterol Drugs Reduced Risk of Prostate Cancer Death
  • “This Is My Last Day on Earth”
  • ONS: Safe Handling of Chemotherapy
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
Click here to subscribe to our newsletter



CancerNetwork on Facebook

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy